정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1843 | Recruiting | COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 | SARS-CoV-2 Infection | Drug: Losartan Drug: Placebo |
Phase 3 | Bassett Healthcare, Reid Health, Goshen Health System | OTHER | 100 | All | 18 Years | Bassett Medical Center, Cooperstown, New York, United States |
| 1842 | Not yet recruiting | COVID Protection After Transplant-Immunosuppression Reduction | Liver Transplant Recipients | Biological: Pfizer-BioNTech COVID-19 Vaccine Booster Biological: Moderna COVID-19 Vaccine Booster Drug: SOC IS Regimen Drug: SOC IS Reduction |
Phase 2 | National Institute of Allergy and Infectious Diseases (NIAID), PPD | NIH | 400 | All | 18 Years | University of California San Francisco Health, San Francisco, California, United States Emory Healthcare, Atlanta, Georgia, United States University of Illinois Health, Chicago, Illinois, United States Ochsner Health, New Orleans, Louisiana, United States Johns Hopkins Institute for Clinical and Translational Research: Broadway Adult Outpatient Clinical Research Unit, Baltimore, Maryland, United States Mt. Sinai Hospital, New York, New York, United States Duke University Medical Center, Durham, North Carolina, United States |
| 1841 | Completed | COVID-19 (VA CURES-1) | COVID-19 | Drug: Convalescent Plasma Other: Masked Saline Placebo |
Phase 3 | VA Office of Research and Development | FED | 75 | All | 18 Years | Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States Orlando VA Medical Center, Orlando, FL, Orlando, Florida, United States James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States John D. Dingell VA Medical Center, Detroit, MI, Detroit, Michigan, United States VA Southern Nevada Healthcare System, North Las Vegas, NV, North Las Vegas, Nevada, United States James J. Peters VA Medical Center, Bronx, NY, Bronx, New York, United States Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States Oklahoma City VA Medical Center, Oklahoma City, OK, Oklahoma City, Oklahoma, United States VA Portland Health Care System, Portland, OR, Portland, Oregon, United States Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia, United States William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison, Wisconsin, United States VA Caribbean Healthcare System, San Juan, PR, San Juan, Puerto Rico |
| 1840 | Recruiting | COVID-19 3rd Dose Vaccine in Transplant Patients | Covid19 | Biological: BNT162b2 vaccine Biological: JNJ-78436735 Vaccine |
Phase 3 | Giselle Guerra | OTHER | 200 | All | 18 Years | University of Miami, Miami, Florida, United States |
| 1839 | Recruiting | COVID-19 Administration of Single-Dose Subcutaneous or Intramuscular Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age | COVID-19 | Drug: casirivimab and imdevimab | Phase 2 | Regeneron Pharmaceuticals | INDUSTRY | 24 | All | ~ 12 Years | Regeneron Study Site, Miami, Florida, United States Regeneron Study Site, Stony Brook, New York, United States |
| 1838 | Recruiting | COVID-19 and Anti-CD14 Treatment Trial | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Biological: anti-CD14 Other: Placebo Drug: remdesivir |
Phase 2 | National Institute of Allergy and Infectious Diseases (NIAID), University of Washington, Implicit Bioscience, Vanderbilt University Medical Center, PPD | NIH | 300 | All | 18 Years | Harbor - UCLA Medical Center, Torrance, California, United States University of Miami Medical Center, Miami Beach, Florida, United States Sarasota Memorial Health Care System, Sarasota, Florida, United States Emory University Medical Center, Atlanta, Georgia, United States Ochsner Health, New Orleans, Louisiana, United States University of Maryland Medical Center, Baltimore, Maryland, United States Baystate Medical Center, Springfield, Massachusetts, United States Cleveland Clinic, Cleveland, Ohio, United States Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States Virginia Mason Medical Center, Seattle, Washington, United States Harborview Medical Center, Seattle, Washington, United States Swedish Medical Center, Seattle, Washington, United States University of Washington Medical Center-Montlake, Seattle, Washington, United States University of Washington Medical Center, Seattle, Washington, United States |
| 1837 | Completed | COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) | Coronavirus | Drug: cholecalciferol 200,000 IU Drug: cholecalciferol 50,000 IU |
Phase 3 | University Hospital, Angers, Mylan Laboratories | OTHER_GOV | 260 | All | 65 Years | CHU Angers, Angers, France CHU Bordeaux, Bordeaux, France CH Le Mans, Le Mans, France CHU Limoges, Limoges, France CHU Nantes, Nantes, France CHU Nice, Nice, France CHU Saint Etienne, Saint Etienne, France CH Saumur, Saumur, France CHU Tours, Tours, France |
